BiotechTube
Home/Uvax Bio/Kevin O'Neill
KO

Kevin O'Neill

Chief Executive Officer

Uvax Bio

Therapeutic Areas

Infectious Diseases

Uvax Bio Pipeline

DrugIndicationPhase
HIV-1 VaccineHIV-1 preventionPre-clinical
Undisclosed Asset 1Infectious DiseaseResearch
Undisclosed Asset 2Infectious DiseaseResearch
Undisclosed Asset 3Infectious DiseaseResearch

Leadership Team at Uvax Bio

PG
Pedro Garbes, MD
Global Medical Lead
MS
Matthijs Schoots
Chief of Staff and Head of Strategic Planning
KB
Keegan Braz Gomes
Director, Preclinical Research
KL
Ke Li, PhD., MBA
CMC Consultant
View full Uvax Bio profile